Welcome to SmartBytes

What Employers Should Actually Demand from PBM Transparency

Meet Lori Daugherty and hear her panel presentation at the SIIA 2026 National Conference, Phoenix, AZ

Everyone says they are transparent. The real question is whether they can prove it.

During the Self-Insurance Institute of America’s 2026 National Conference “Upend The Status Quo” session, RxLogic CEO Lori Daugherty will join other industry leaders to examine how employers can rethink longstanding benefit practices and move beyond opaque pharmacy benefit models. At the center of that discussion is a question the industry can no longer avoid. What separates organizations that claim transparency from those that can prove it?

Transparency has become one of the most widely used terms in pharmacy benefits but there is still no shared industry definition. One organization may use it to describe pass-through pricing. Another may point to a periodic report. An employer may receive more data than before and still lack the information needed to verify how claims were priced, rebates were handled or compensation was earned.

That distinction is becoming more important with The Consolidated Appropriations Act of 2026 establishing significant new federal requirements related to pharmacy benefit management services, including greater disclosure of pricing and compensation, rebate and other remuneration requirements, reporting obligations and enhanced audit rights. The Department of Labor has separately proposed additional requirements governing disclosures of PBM compensation and financial arrangements to fiduciaries of self-insured ERISA group health plans.

RxLogic provides the independent technology infrastructure needed to produce that evidence. Claims adjudication, rebate administration, manufacturer programs and financial workflows operate within a connected, configurable environment where activity can be tracked at the transaction level.

A Report Is Not the Same as Transparency

Reports remain important but true transparency begins before a report is generated. It exists within the rules, data and workflows that produce each result.

Employers should expect access to claim-level pricing information, rebate activity, direct and indirect compensation, contractual terms and the records needed to test whether agreed-upon arrangements were followed. They should also be able to determine who owns the data, how quickly it is available and whether an independent audit can verify it.

If an organization cannot reconstruct a transaction from the original claim through rebate and payment activity, transparency remains difficult to prove. Producing another summary after the fact does not resolve that limitation.

The RFP Must Test the Infrastructure

Pass-through pricing and rebate guarantees remain important, but they no longer provide a complete basis for evaluating a PBM or technology partner. Employers issuing an RFP should also ask:

  • Can pricing decisions be traced to the rules applied at adjudication?
  • Are rebate submissions, receipts, rejections and payments documented at the claim level?
  • Can financial outcomes be reconciled to claims without relying on spreadsheets or disconnected systems?
  • Does the platform preserve an audit trail when plan rules, formularies or programs change?
  • Can the organization provide data in a usable format without delay or restriction?

These questions reveal whether transparency is part of the operating model or a reporting layer added after the work is complete.

The Next Generation Will Operate Differently

The next generation of pharmacy benefit organizations will not be distinguished by a “transparent” label – they will be distinguished by how their systems work.

Claims adjudication, rebate administration, manufacturer affordability programs and financial reporting can no longer function as isolated processes. When these activities are disconnected, employers face fragmented data, manual reconciliation and limited visibility into how financial results were produced.

RxLogic connects these functions through an independent, cloud-native platform. Configurable rules are applied in real time, while claim-level data and documented workflows give clients the visibility needed to evaluate performance. Because RxLogic operates as an independent technology and services platform and does not retain rebates, steer claims for its own economic benefit or monetize spread pricing, clients retain control over plan design, vendor relationships and program strategy.

Proof Will Define the Market

Over the next three to five years, the organizations that lead the market will be those that can substantiate their claims of transparency continuously. They will be able to show how each outcome was produced, provide complete data, support meaningful audits and adapt as federal requirements evolve. Employers don’t need another definition of transparency -- they need evidence and the infrastructure capable of producing it.

Connect with RxLogic to see how independent, configurable technology can provide the operational proof required for accountable pharmacy benefit management.


RxLogic LinkedIn

Past Issues

RxLogic's Pharmaceutical Manufacturer Program Administration

Program strategy only works if it holds up in execution.

RxLogic gives pharmaceutical manufacturers configurable infrastructure to administer copay, discount card, buy-down and direct-to-consumer programs, backed by real-time claims adjudication across pharmacy networks, PBMs and program partners. Claim-level reporting shows exactly how eligibility, pricing and savings play out downstream, while audit-ready records and API-first integration keep programs traceable and adaptable.

Manufacturers get the visibility to confirm savings are reaching patients, without giving up control over program design or data.

From the RxLogic Blog

Pharmacy Benefit Management Collaboration

PBM Reform is Turning Transparency Into an Infrastructure Requirement

PBM reform is raising the bar for anyone responsible for pricing claims, managing rebates and proving how benefit dollars are spent. In our recently published blog, RxLogic CEO Lori Daugherty breaks down what this shift means for the pharmacy benefit operations industry. Lori discusses why legacy reporting, built on spreadsheets and after-the-fact audits, can no longer explain modern pharmacy benefit operations.

We explore how the CAA of 2026 and a proposed DOL rule are pushing organizations toward claim-level traceability, and why technology partners like RxLogic are becoming essential for embedding transparency directly into the claims workflow rather than bolting it on after the fact.

Pharmacy Professionals Discussing Benefits in Modern Office

PBM Reform is Changing the Operating Environment for Manufacturer Programs

Pharmaceutical manufacturers aren't the direct target of PBM reform, but their affordability and patient support programs still operate inside the same pharmacy benefit system. In our blog, RxLogic SVP of Specialty Pharmacy Services Ann Beal breaks down what this shift means for manufacturers.

Ann discusses how rebate planning, copay and buy-down execution, and savings delivery at the pharmacy counter all depend on downstream operations manufacturers don't directly control. We explore why claim-level data is essential for separating true market access issues from execution failures, and why technology partners like RxLogic are becoming essential for turning program requirements into consistent, traceable action.

RxLogic in the News

 RxLogic CEO Lori Daugherty to Address PBM Transparency and Technology Infrastructure at SIIA National Conference 2026 

 

RxLogic Named No. 306 on the 2026 Inc. 5000 List the Most Prestigious Ranking of Americas Fastest Growing Private Companies

 

RxLogic Appoints Doug Benson Vice President Strategic Account Planning Success

RxLogic on the Road

RxLogic is Heading to the WLT 2026 Client Conference

RxLogic is heading to the WLT Client Conference at the Hilton in Clearwater Beach, FL, September 14–17. CEO Lori Daugherty will join the panel "Behind the Mask (PBM Legislation)," discussing PBM fiduciary responsibility amid new DOL disclosure requirements and the shift away from spread pricing. Doug Benson, VP of Strategic Account Planning & Success, and Billy Buckles, SVP of Business Development & Implementation, will be on-site in Lounge #3 Exhibitor - Salons FG ready to talk through how RxLogic's platform helps TPAs stay ahead of today's compliance and cost pressures. To set up time with Doug and Billy at the conference, reach out to Jessica Rodriguez at jrodriguez@rxlogic.com.

RxLogic Will be Attending, Exhibiting and Speaking at the 2026 Self-Insurance Institute of Ameria National Conference 2026

RxLogic is heading to the Self-Insurance Institute of America National Conference, October 11–13 at the JW Marriott Desert Ridge in Phoenix, AZ. RxLogic’s CEO Lori Daugherty will join the panel "Upend the Status Quo: Think Creatively About Medical & Pharmacy Benefits" on Monday, October 12, from 1:30–2:45 p.m. MST in Grand Sonoran E, discussing why PBM evaluation must extend beyond pricing models to the infrastructure behind claims adjudication, rebate administration and financial reporting.

Lori, Billy Buckles, SVP of Business Development & Implementation, Doug Benson, VP of Strategic Account Planning & Success, Ann Beal, SVP of Specialty Pharmacy Services and Marc Albers, SVP of Strategy, will be on-site at Booth 207 and 209 ready to talk through how RxLogic helps self-insured employers move from promises of transparency to proof. Stop by our booths to connect with the us in Phoenix! To set up time with RxLogic at the conference, reach out to Jessica Rodriguez at jrodriguez@rxlogic.com.